Piper Jaffray Starts Nanosphere (NSPH) at Buy

December 11, 2007 8:09 AM EST Send to a Friend
Get Alerts NSPH Hot Sheet
Price: $0.44 --0%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 29 | Down: 45 | New: 4
Trade NSPH Now!
Join SI Premium – FREE
Piper Jaffray initiates coverage on Nanosphere (Nasdaq: NSPH) with a Buy rating and a $17 price target.

The firm said Nanosphere's core technology is solid and its recent FDA approval for its Verigene molecular diagnostics instrument will lead to long-term revenue growth.

Nanosphere, Inc. develops, manufactures, and markets a molecular diagnostics platform, the Verigene System, that enables genomic and protein testing on a single platform.

You May Also Be Interested In





Related Categories

New Coverage

Add Your Comment